Quantitative Analysis of Fetal DNA in Maternal Plasma in Pathological Conditions Associated with Placental Abnormalities
- 1 September 2001
- journal article
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 945 (1), 132-137
- https://doi.org/10.1111/j.1749-6632.2001.tb03873.x
Abstract
An increased fetal DNA concentration in maternal plasma has been observed in placental pathological conditions associated with hypertension and preeclampsia. To confirm these data, we performed real‐time quantitative PCR on the SRY gene in a group of physiological and pathological male‐bearing pregnancies. In 78 physiological pregnancies, fetal DNA concentration in maternal plasma was 20.7, 13.4, 23.6, and 74.8 genome‐equivalents (g.e.)/mL during the first, second, and third trimesters and at term, respectively. In 10 preeclamptic women, fetal DNA concentration ranged from 59.3 to 615.2 g.e./mL (median: 332.9). In 7 women with preeclampsia and IUGR (intrauterine growth retardation), fetal DNA ranged from 96.5 to 859 g.e./mL (median: 146.8). In 4 women with IUGR and hypertension, fetal DNA ranged from 34 to 473.5 g.e./mL (median: 142.4). In 3 patients with IUGR, fetal DNA ranged from 168.6 to 519.7 g.e./mL (median: 308.1). In 2 patients with IUGR and HELLP (hemolysis, elevated liver enzymes, and low platelet count) syndrome, fetal DNA concentration ranged from 105 to 394.1 g.e./mL (median: 249.7). Four women who developed preeclampsia some weeks later showed fetal DNA levels within the physiological range. These data suggest that increased fetal DNA concentrations might represent a valuable marker of placental abnormalities and suggest that this rise may precede clinical manifestation of preeclampsia by only a few weeks.Keywords
This publication has 16 references indexed in Scilit:
- Preeclampsia Is Associated with Widespread Apoptosis of Placental Cytotrophoblasts within the Uterine WallThe American Journal of Pathology, 1999
- Disturbed Feto-Maternal Cell Traffic in PreeclampsiaPublished by Ovid Technologies (Wolters Kluwer Health) ,1998
- Quantitative Analysis of Fetal DNA in Maternal Plasma and Serum: Implications for Noninvasive Prenatal DiagnosisAmerican Journal of Human Genetics, 1998
- Trial of Calcium to Prevent PreeclampsiaNew England Journal of Medicine, 1997
- HYPERTENSION IN PREGNANCY: Current Concepts of PreeclampsiaAnnual Review of Medicine, 1997
- Risk factors for preeclampsia in healthy nulliparous women: A prospective multicenter studyAmerican Journal of Obstetrics and Gynecology, 1995
- The interrelationship of eclampsia, HELLP syndrome, and prematurity: cofactors for significant maternal and perinatal riskBJOG: An International Journal of Obstetrics and Gynaecology, 1993
- Preeclampsia: An endothelial cell disorderAmerican Journal of Obstetrics and Gynecology, 1989
- Inadequate maternal vascular response to placentation in pregnancies complicated by pre‐eclampsia and by small‐for‐gestational age infantsBJOG: An International Journal of Obstetrics and Gynaecology, 1986
- A standard of fetal growth for the united states of AmericaAmerican Journal of Obstetrics and Gynecology, 1976